Serum antibodies from Parkinson's disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression

Springer Science and Business Media LLC - 2006
Victor C. Huber1, Tapan Kumar Mondal1, Stewart A. Factor2, Richard F. Seegal3, David A. Lawrence1
1Wadsworth Center, New York State Department of Health, Albany, NY, 12201, USA
2Parkinson's Disease & Movement Disorders Center, Albany Medical College, Albany, NY, 12208, USA
3Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA

Tóm tắt

Abstract Evidence exists suggesting that the immune system may contribute to the severity of idiopathic Parkinson's disease (IPD). The data presented here demonstrates that antibodies in the sera of patients with IPD have increased binding affinity to dopaminergic (DA) neuronal (MN9D cell line) membrane antigens in comparison to antibodies in sera from healthy controls. In general, the degree of antibody reactivity to these antigens of the mouse MN9D cell line appears to correlate well with the disease severity of the IPD patients contributing sera, based on the total UPDRS scores. Surprisingly, the sera from IPD patients enhanced the DA content of MN9D cells differentiated with n-butyrate; the n-butyrate-differentiated MN9D cells had a greater concentration of DA (DA/mg total protein) than undifferentiated MN9D cells, especially early in culture. Although the IPD sera did not directly harm MN9D cellular viability or DA production, in the presence of the N9 microglial cell line, the amount of DA present in cultures of untreated or n-butyrate-treated MN9D cells was lowered by the IPD sera. The results suggest the involvement of antibodies in the decline of dopamine production and, thus, the potential of immune system participation in IPD.

Từ khóa


Tài liệu tham khảo

Lang A, Lozano A: Parkinson's disease: First of two parts. N Engl J Med. 1998, 339: 1044-1053. 10.1056/NEJM199810083391506.

Lang A, Lozano A: Parkinson's disease: Second of two parts. N Engl J Med. 1998, 339: 1130-1143. 10.1056/NEJM199810153391607.

Beal M: Experimental models of Parkinson's disease. Nat Rev Neurosci. 2001, 2: 325-334. 10.1038/35072550.

Olanow C, Tatton W: Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci. 1999, 22: 123-144. 10.1146/annurev.neuro.22.1.123.

McInerney-Leo A, Hadley D, Gwinn-Hardy K, Hardy J: Genetic testing in Parkinson's disease. Mov Disord. 2005, 20: 1-10. 10.1002/mds.20316.

McGeer P, Itagaki S, Akiyama H, McGeer E: Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol. 1988, 24: 574-576. 10.1002/ana.410240415.

McGeer P, Itagaki S, Boyes B, McGeer E: Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988, 38: 1285-1291.

Fiszer U: Does Parkinson's disease have an immunological basis? The evidence and its therapeutic implications. BioDrugs. 2001, 15: 351-355. 10.2165/00063030-200115060-00001.

Liberatore G, Jackson-Lewis V, Vukosavic S, Mandir A, Vila M, McAuliffe W, Dawson V, Dawson T, Przedborski S: Inducible nitric oxide synthase stimulates opaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med. 1999, 5: 1403-1409. 10.1038/70978.

Kurkowska-Jastrzebska I, Wronska A, Kohutnicka M, Czlonkowski A, Czlonkowska A: The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp Neurol. 1999, 156: 50-61. 10.1006/exnr.1998.6993.

Teismann P, Tieu K, Choi D, Wu D, Naini A, Hunot S, Vila M, Jackson-Lewis V, Przedborski S: Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci USA. 2003, 100: 5473-5478. 10.1073/pnas.0837397100.

Kohutnicka M, Lewandowska E, Kurkowska-Jastrzebska I, Czlonkowski A, Czlonkowska A: Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Immunopharmacology. 1998, 39: 167-180. 10.1016/S0162-3109(98)00022-8.

Nagatsu T, Mogi M, Ichinose H, Togari A: Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl. 2000, 277-290.

Czlonkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Czlonkowski A: Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. Neurodegeneration. 1996, 5: 137-143. 10.1006/neur.1996.0020.

Czlonkowska A, Kurkowska-Jastrzebska I, Czlonkowski A, Peter D, Stefano G: Immune rocesses in the pathogenesis of Parkinson's disease – a potential role for microglia and nitric oxide. Med Sci Monit. 2002, 8: RA165-RA177.

Nagatsu T, Mogi M, Ichinose H, Togari A: Cytokines in Parkinson's disease. J Neural Transm Suppl. 2000, 143-151.

Le W, Rowe D, Jankovic J, Xie W, Appel S: Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Arch Neurol. 1999, 56: 194-200. 10.1001/archneur.56.2.194.

Rowe D, Le W, Smith R, Appel S: Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation. J Neurosci Res. 1998, 53: 551-558. 10.1002/(SICI)1097-4547(19980901)53:5<551::AID-JNR5>3.0.CO;2-8.

McRae-Degueurce A, Rosengren L, Haglid K, Booj S, Gottfries C, Granerus A, Dahlstrom A: Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson's disease cases. Neurochem Res. 1988, 13: 679-684. 10.1007/BF00973287.

McRae D, Gottfries C, Karlsson I, Svennerholm L, Dahlstrom A: Antibodies in the CSF of a Parkinson patient recognizes neurons in rat mesencephalic regions. Acta Physiol Scand. 1986, 126: 313-315.

Loeffler D, Brickman C, Kapatos G, Peter J, LeWitt P: Anti-Neuronal Antibodies and Other Markers of Immune System Activation in Parkinson's Disease Cerebrospinal Fluid. Neurodegeneration. 1992, 1: 145-153.

Dahlstrom A, Wigander A, Lundmark K, Gottfries C, Carvey P, McRae A: Investigations on auto-antibodies in Alzheimer's and Parkinson's diseases, using defined neuronal cultures. J Neural Transm Suppl. 1990, 29: 195-206.

Carvey P, McRae A, Lint T, Ptak L, Lo E, Goetz C, Klawans H: The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 1991, 41: 53-58.

Pouplard A, Emile J: Autoimmunity in Parkinson's disease. Adv Neurol. 1984, 40: 307-313.

Chen S, Le W, Xie W, Alexianu M, Engelhardt J, Siklos L, Appel S: Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Arch Neurol. 1998, 55: 1075-1080. 10.1001/archneur.55.8.1075.

Le W, Rowe D, Xie W, Ortiz I, He Y, Appel S: Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci. 2001, 21: 8447-8455.

He Y, Le W, Appel S: Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Exp Neurol. 2002, 176: 322-327. 10.1006/exnr.2002.7946.

Choi H, Won L, Kontur P, Hammond D, Fox A, Wainer B, Hoffmann P, Heller A: Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 1991, 552: 67-76. 10.1016/0006-8993(91)90661-E.

Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini S, Ricciardi-Castagnoli P: Monokine production by microglial cell clones. Eur J Immunol. 1989, 19: 1443-1448.

Corradin S, Mauel J, Donini S, Quattrocchi E, Ricciardi-Castagnoli P: Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia. 1993, 7: 255-262. 10.1002/glia.440070309.

Matsuki N: Measurement of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction activity and lactate dehydrogenase release using MTT. Neurosci Res. 2000, 38: 325-329. 10.1016/S0168-0102(00)00188-7.

Duncan D, Lawrence D: Residual activation events functional after irradiation of mouse splenic lymphocytes. Radiation Res. 1991, 125: 6-13.

Narendran A, Hoffman S: Identification of autoantibody reactive integral brain membrane antigens. A two-dimensional analysis. J Immunol Methods. 1988, 114: 227-234. 10.1016/0022-1759(88)90178-0.

Cao L, Lawrence D: Suppression of host resistance to Listeria moncytogenes by acute cold/restraint stress: lack of direct IL-6 involvement. J Neuroimmunol. 2002, 133: 132-143. 10.1016/S0165-5728(02)00371-5.

Seegal R, Brosch K, Bush B: High-performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma. J Chromatogr. 1986, 377: 131-144.

Wang J, Shum A, Ho Y: Oxidative neurotoxicity in rat cerebral cortex neurons: synergistic effects of H2O2 and NO on apoptosis involving activation of p38 mitogen-activated protein kinase and caspase-3. J Neurosci Res. 2003, 72: 508-519. 10.1002/jnr.10597.

Collins M: Alkaloids, alcohol and Parkinson's disease. Parkinsonism Relat Disord. 2002, 8: 417-422. 10.1016/S1353-8020(02)00024-X.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả